OBO
- 产品代码
- OBO
- 器械名称
- Tomography, Optical Coherence
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 886.1570
- FDA 专业组
- Ophthalmic
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 15 件
- 其中 Summary 已存档
- 14 份,可直接下载
- FDA 历史累计 510(k)
- 66 件(全部年份;本站只收录近三年的明细)
FDA 分类定义
Viewing, imaging, measurement, and analysis of ocular structures. Diagnostic device to aid in the detection and management of various ocular diseases.
该代码近三年的 510(k)(15 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K253837 | 2026-05-07 | Heidelberg Engineering GmbH | SPECTRALIS HRA+OCT and variants; SPECTRALIS with Fle | FDA |
| K252633 | 2025-12-23 | Cylite Pty. , Ltd. | UNITY DX (UDX) | |
| K250553 | 2025-07-18 | Tomey Corporation | Tomey Cornea/Anterior Segment OCT (CASIA2) | |
| K250868 | 2025-05-12 | Heidelberg Engineering GmbH | SPECTRALIS HRA+OCT and variants | |
| K240924 | 2024-12-13 | Heidelberg Engineering GmbH | Anterion | |
| K241163 | 2024-10-11 | Heidelberg Engineering GmbH | SPECTRALIS with Flex Module | |
| K241081 | 2024-07-17 | Topcon Corporation | 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maes | |
| K240221 | 2024-07-01 | Heidelberg Engineering GmbH | SPECTRALIS HRA+OCT and variants | |
| K233933 | 2024-05-17 | Carl Zeiss Meditec, Inc. | CIRRUS HD-OCT Model 6000 | |
| K233602 | 2024-05-09 | Optos Plc. | P200TE (A10700) | |
| K233561 | 2024-04-10 | Topcon Corporation | 3D Optical Coherence Tomography (3D OCT-1(type: Maes | |
| K233421 | 2024-03-08 | Carl Zeiss Meditec, AG | RESCAN 700 | |
| K231222 | 2023-10-30 | Topcon Corporation | 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maest | |
| K223557 | 2023-10-20 | Heidelberg Engineering GmbH | SPECTRALIS HRA+OCT and variants | |
| K230897 | 2023-10-11 | Heidelberg Engineering GmbH | Anterion |
FDA 官方分类页: OBO
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。